Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 3, 2015
Living and deceased organ donation should be financially neutral actsF L Delmonico, D Martin, B Domínguez-Gil, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2008
Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeysR N Smith, T Kawai, S Boskovic, et al.
Transplantation|November 7, 1999
Outcome of transplantation of organs procured from bacteremic donorsR B Freeman, I Giatras, M E Falagas, et al.
Transplantation|March 8, 2000
Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipientsJ A Fishman, M T Doran, S A Volpicelli, et al.
Human Immunology|February 1, 1984
Antigenic polymorphism of the T4 differentiation antigen expressed on human T helper/inducer lymphocytesT C Fuller, J E Trevithick, A A Fuller, et al.
World Journal of Surgery|August 31, 2012
The faltering solid organ donor pool in the United States (2001-2010)Reza F Saidi, James F Markmann, Nicolas Jabbour, et al.
Transplantation|March 1, 1992
The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipientsS L Wee, D M Stroka, F I Preffer, et al.
Transplantation|May 1, 1986
Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppressionG J Jaffers, T C Fuller, A B Cosimi, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 20, 2009
Living donor kidney transplantation with multiple arteries: recent increase in modern era of laparoscopic donor nephrectomyReza Saidi, Tatsuo Kawai, Peter Kennealey, et al.
Transplantation|January 12, 1999
Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapyN Turgeon, J A Fishman, N Basgoz, et al.
Pageof 24